PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Appili Therapeutics Inc. (APLI.TO)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISINCA03783R1073
CUSIP03783R107
SectorHealthcare
IndustryBiotechnology

Highlights

Market CapCA$4.24M
EPS-CA$0.04
Revenue (TTM)CA$1.15M
Gross Profit (TTM)CA$1.39M
EBITDA (TTM)-CA$7.85M
Year RangeCA$0.03 - CA$0.08
Target PriceCA$0.15
Short %0.56%
Short Ratio0.10

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Appili Therapeutics Inc.

Popular comparisons: APLI.TO vs. VRTX

Performance

Performance Chart

The chart shows the growth of an initial investment of CA$10,000 in Appili Therapeutics Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-100.00%-50.00%0.00%50.00%100.00%December2024FebruaryMarchAprilMay
-95.62%
87.88%
APLI.TO (Appili Therapeutics Inc.)
Benchmark (^GSPC)

S&P 500

Returns By Period

Appili Therapeutics Inc. had a return of 0.00% year-to-date (YTD) and 0.00% in the last 12 months.


PeriodReturnBenchmark
Year-To-Date0.00%11.29%
1 month-12.50%6.86%
6 months0.00%16.73%
1 year0.00%26.63%
5 years (annualized)N/A13.23%
10 years (annualized)N/A10.84%

Monthly Returns

The table below presents the monthly returns of APLI.TO, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2024-14.29%0.00%16.67%0.00%0.00%
202311.11%-20.00%0.00%0.00%0.00%-25.00%83.33%-9.09%10.00%-36.36%0.00%0.00%-22.22%
2022-0.00%21.74%-14.29%-8.33%-36.36%7.14%-6.67%-14.29%-8.33%-9.09%10.00%-18.18%-60.87%
2021-18.03%7.00%3.74%6.31%-27.12%-17.44%14.08%-2.47%36.71%-28.70%-80.52%-23.33%-90.57%
202028.00%-28.13%-1.45%120.59%2.00%-35.95%-5.10%-16.13%73.08%8.15%-13.70%-3.17%62.67%
2019-6.25%-26.67%-9.09%-8.00%13.04%11.54%29.31%-6.25%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of APLI.TO is 51, suggesting that the investment has average results relative to other stocks in terms of risk-adjusted performance. This ranking is determined by the cumulative values of the indicators listed below.


The Risk-Adjusted Performance Rank of APLI.TO is 5151
APLI.TO (Appili Therapeutics Inc.)
The Sharpe Ratio Rank of APLI.TO is 4242Sharpe Ratio Rank
The Sortino Ratio Rank of APLI.TO is 6464Sortino Ratio Rank
The Omega Ratio Rank of APLI.TO is 6565Omega Ratio Rank
The Calmar Ratio Rank of APLI.TO is 4343Calmar Ratio Rank
The Martin Ratio Rank of APLI.TO is 4343Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Appili Therapeutics Inc. (APLI.TO) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


APLI.TO
Sharpe ratio
The chart of Sharpe ratio for APLI.TO, currently valued at 0.00, compared to the broader market-2.00-1.000.001.002.003.004.000.00
Sortino ratio
The chart of Sortino ratio for APLI.TO, currently valued at 1.24, compared to the broader market-4.00-2.000.002.004.006.001.24
Omega ratio
The chart of Omega ratio for APLI.TO, currently valued at 1.18, compared to the broader market0.501.001.502.001.18
Calmar ratio
The chart of Calmar ratio for APLI.TO, currently valued at 0.00, compared to the broader market0.002.004.006.000.00
Martin ratio
The chart of Martin ratio for APLI.TO, currently valued at 0.00, compared to the broader market-200,000.00-150,000.00-100,000.00-50,000.000.000.00
^GSPC
Sharpe ratio
The chart of Sharpe ratio for ^GSPC, currently valued at 2.30, compared to the broader market-2.00-1.000.001.002.003.004.002.30
Sortino ratio
The chart of Sortino ratio for ^GSPC, currently valued at 3.26, compared to the broader market-4.00-2.000.002.004.006.003.26
Omega ratio
The chart of Omega ratio for ^GSPC, currently valued at 1.40, compared to the broader market0.501.001.502.001.40
Calmar ratio
The chart of Calmar ratio for ^GSPC, currently valued at 1.86, compared to the broader market0.002.004.006.001.86
Martin ratio
The chart of Martin ratio for ^GSPC, currently valued at 8.76, compared to the broader market-200,000.00-150,000.00-100,000.00-50,000.000.008.76

Sharpe Ratio

The current Appili Therapeutics Inc. Sharpe ratio is 0.00. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of Appili Therapeutics Inc. with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio0.001.002.003.00December2024FebruaryMarchAprilMay0
2.87
APLI.TO (Appili Therapeutics Inc.)
Benchmark (^GSPC)

Dividends

Dividend History


Appili Therapeutics Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%December2024FebruaryMarchAprilMay
-98.13%
-0.03%
APLI.TO (Appili Therapeutics Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Appili Therapeutics Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Appili Therapeutics Inc. was 98.66%, occurring on Jan 29, 2024. The portfolio has not yet recovered.

The current Appili Therapeutics Inc. drawdown is 98.13%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-98.66%May 20, 2020927Jan 29, 2024
-59.44%Jun 28, 201936Aug 20, 2019111Jan 29, 2020147
-48.45%Jan 31, 202031Mar 16, 202015Apr 6, 202046
-11.82%Apr 20, 20202Apr 21, 20202Apr 23, 20204
-7.07%Apr 9, 20202Apr 13, 20201Apr 14, 20203

Volatility

Volatility Chart

The current Appili Therapeutics Inc. volatility is 27.37%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%10.00%20.00%30.00%40.00%50.00%60.00%December2024FebruaryMarchAprilMay
27.37%
2.89%
APLI.TO (Appili Therapeutics Inc.)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Appili Therapeutics Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Income Statement


Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly

TTM
Revenue

Total Revenue

0.00

Cost Of Revenue

0.00

Gross Profit

0.00
Operating Expenses

Selling, General & Admin Expenses

0.00

R&D Expenses

0.00

Total Operating Expenses

0.00
Income

Income Before Tax

0.00

Operating Income

0.00

EBIT

0.00

Earnings From Continuing Operations

0.00

Net Income

0.00

Income Tax Expense

0.00

Interest Expense

0.00

Other Non-Operating Income (Expenses)

0.00

Extraordinary Items

0.00

Discontinued Operations

0.00

Effect Of Accounting Charges

0.00

Non Recurring

0.00

Minority Interest

0.00

Other Items

0.00
Values in undefined except per share items